CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome, Inc., today announced the start of its early technology access program for knomeCLINIC, a software suite designed to help medical researchers and clinicians interpret human genomes for biological relevance. Clinics accepted into the early access program will be given installation priority, access to pilot programs and pre-release prototypes, and the ability to influence knomeCLINIC’s feature set upon general release.
